Vimta Labs Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

Net profit of Vimta Labs rose 15.23% to Rs 21.11 crore in the quarter ended March 2026 as against Rs 18.32 crore during the previous quarter ended March 2025. Sales rose 15.68% to Rs 109.25 crore in the quarter ended March 2026 as against Rs 94.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 15.10% to Rs 77.51 crore in the year ended March 2026 as against Rs 67.34 crore during the previous year ended March 2025. Sales rose 18.41% to Rs 407.29 crore in the year ended March 2026 as against Rs 343.98 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Vimta Labs announced that the Board of Directors of the Company at its meeting held on 6 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 100%) , subject to the approval of the shareholders.

Vimta Labs will hold a meeting of the Board of Directors of the Company on 6 May 2026.

Net profit of Vimta Labs declined 18.19% to Rs 17.59 crore in the quarter ended December 2025 as against Rs 21.50 crore during the previous quarter ended December 2024. Sales rose 9.69% to Rs 98.63 crore in the quarter ended December 2025 as against Rs 89.92 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News